Patients should be monitored for a year after stopping weight loss jabs to prevent them piling the pounds back on, new ...

Novo Nordisk, the Danish maker of the wildly popular Ozempic and Wegovy drugs used for weight loss, was downgraded due to ...

Shares of Hims and Hers Health (NYSE:HIMS) slid 14% in premarket trading following the telehealth company’s announcement of ...

The National Institute for Health and Care Excellence (Nice) issues advice as 1.5 million Brits are using weight loss ...

Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some ...

Health chiefs have raised concerns about patients regaining weight after stopping popular weight-loss drugs such as Wegovy and Mounjaro, calling for robust support to prevent them from piling on the ...

Experts say NHS patients should be monitored for at least a year after treatment ends, with tailored support provided if ...

People coming off obesity jabs like Wegovy and Mounjaro should have check-ups for at least a year to make sure they don't ...

Swiss generic drug manufacturer Sandoz plans to launch unbranded weight-loss drugs in Canada at discounts of up to 70% compared to branded versions once patents begin to expire next year, CEO Richard ...

The company has big ambitions. It wants to reach at least $6.5 billion in sales by 2030. In the short term, as it tries to steer its consumers to high-end daily products, Chief Financial Officer Yemi ...

Patients coming off Wegovy or Mounjaro should have support and advice for at least a year afterwards, NHS told.

The National Institute for Health and Care Excellence (Nice) is concerned about the number of people regaining weight after ...